Environmental exposure to carbon nanotubes results in systemic distribution via the circulatory system: hepatotoxicity and central nervous system involvement. by Pagani, Arianna
 1 
UNIVERSITA’ DEGLI STUDI DELL’INSUBRIA 
Facoltà di Medicina e Chirurgia 
Dottorato di Ricerca in Biologia Cellulare e Molecolare 
XXV Ciclo 
Scuola di Dottorato in Scienze Mediche e Biologiche 
Coordinatore: Prof.ssa Magda de Eguileor 
 
Ph. D. Thesis 
ENVIRONMENTAL EXPOSURE TO CARBON 
NANOTUBES RESULTS IN SYSTEMIC 
DISTRIBUTION VIA THE CIRCULATORY SYSTEM: 
HEPATOTOXICITY AND CENTRAL NERVOUS 
SYSTEM INVOLVEMENT 
 
Supervisors : Prof. DOUGLAS M. NOONAN 




Dr. Arianna Pagani 
 
 




SUMMARY .............................................................................................................................. 4 
INTRODUCTION ...................................................................................................................... 5 
NANOTECHNOLOGY AND CARBON NANOTUBES ............................................................... 5 
Physical Characteristics and Properties of Carbon Nanotubes ...................................... 6 
Current Applications of Carbon Nanotubes ................................................................... 7 
Environmental and Occupational Exposures to Carbon Nanotubes .............................. 9 
NANOTOXICOLOGY AND TOXICITY OF CARBON NANOTUBES ......................................... 12 
Toxicity of nanoparticles .............................................................................................. 12 
Methodology to Assess the Potential Toxicity of Carbon Nanotubes .......................... 13 
Fibre toxicology and the experience with asbestos ..................................................... 14 
Pulmonary toxicity of CNTs .......................................................................................... 16 
Hepatotoxicity of CNTs................................................................................................. 18 
AIM ....................................................................................................................................... 20 
MATERIALS AND METHODS ................................................................................................. 22 
CNT  preparation .............................................................................................................. 22 
Quantification of SWCNT concentrations ........................................................................ 23 
Study design and animals ................................................................................................. 23 
Optical microscopy ........................................................................................................... 25 
Metabolic analysis ............................................................................................................ 26 
Serum biochemical analysis ............................................................................................. 26 
Flow cytometry analysis ................................................................................................... 27 
 3 
Determination of the presence of nanotube and their localization by Scanning 
Electron Microscopy ........................................................................................................ 28 
RESULTS ............................................................................................................................... 29 
Macroscopic effects of MWCNTs in environmentally exposed mice. .............................. 29 
Accumulation of MWCNTs in environmentally exposure mice. ...................................... 29 
Dark deposits of material in exposed mice are MWCNTs aggregates. ............................ 30 
Hepatic steatosis in animals environmentally exposed to MWCNTs ............................... 31 
Intravenously injected CNTs accumulate in liver and induce hepatic damage ................ 32 
SWCNTs injection impairs metabolic functions ............................................................... 33 
SWCNTs can induce chronic hepatic damage .................................................................. 34 
SWCNTs introduced into the blood stream are captured by RES system inducing 
inflammation and choleostasis ........................................................................................ 35 
DISCUSSION .......................................................................................................................... 36 
FIGURES ................................................................................................................................ 41 
TABLES .................................................................................................................................. 50 











Carbon nanotubes (CNTs) are among the most promising nanomaterials 
and their interesting properties are now exploited in many fields of 
technology and biomedical applications. However, the rapid growth of 
CNT employment raises concerns about the potential risks and toxicities 
to public health, environment and workers associated with the 
manufacture and use of these new materials. Here we investigate the 
main routes of entry following environmental exposure to CNTs, their 
localization and possible role in inducing inflammation and specific 
pathologies, using a novel rodent model. Following environmental 
exposure, we observed that CNTs rapidly accumulate in the lungs and 
brain, later reaching other organs including the liver, where steatosis 
was found after chronic exposure to CNTs. Since SWCNTs are 
considered for potential medical applications ad their toxicity is similar 
to that of MWCNTs, we further examined the effects of chronic 
intravenous SWCNT administration, which resulted in a chronic 
inflammatory condition particularly evident in the liver that was 
associated with a choleostasis-like syndrome. Our data suggest that after 
environmental exposure, CNTs can rapidly enter and diffuse in the 
organism via the blood stream, in addition to the lungs, which appear to 
have a capacity to clear CNTs, the liver may be the major site of CNT 
induced damage, where long term accumulation results in inflammation, 






NANOTECHNOLOGY AND CARBON NANOTUBES 
 
Materials exhibit unique properties at the nanometer scale: 
nanotechnology is the art of manipulating materials in nanometer 
dimensions to take advantage from these unique properties.  
Nanotechnologies are currently considered one of the most innovative 
technologies with a vast variety of applications. Nanostructures, a term 
which comprehends nanoparticles, nanotubes, and fullerens, with 
interesting chemical and physical properties are manufactured and used 
in the industrial field in many numerous ways.   
Many nanotech products are now commercially available in a sector that 
shows explosive growth. Among the nanoparticles, carbon nanotubes 
(CNTs) are already widely used in industry and their applications are 
increasing constantly. 
CNTs are major building blocks of this new technology: they possess 
unique electrical, mechanical, and thermal properties, with potential 
broad applications in the electronics, computer, aerospace and other 
industries. However, reasonable concerns are being expressed about 
potential risks to workers, public health, and the environment through 
manufacture, use, and disposition of these newly developed materials. 
This requires a careful assessment of potential unexpected biological 
interactions and toxicities, in a new field known as nanotoxicology [1]. 
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Physical Characteristics and Properties of Carbon Nanotubes  
 
CNTs are cylinders of one or several layer(s) of graphene sheets, 
exhibiting unique physical, mechanical, conductive, thermal and 
chemical properties [2,3]. Depending on the number of graphene layers 
from which a single nanotube is composed, CNTs are classified into 
single- walled carbon nanotubes (SWCNTs) constructed of a single sheet 
of graphite, while multi- walled carbon nanotubes (MWCNTs) are larger 
and consist of multiple concentric graphite cylinders of increasing 
diameter.  
SWCNTs are considered one-dimensional (1-D) nanomaterials [1] and 
show important optical properties, as strong optical absorption in the 
near-infrared (NIR) that make theme utilized for photothermal therapy 
[4,5]. They can be employed for biological imaging, as SWCNTs emit in 
the biological tissue transparency window [6,7]  
In contrast to SWCNTs, MWCNTs exhibit less important optical 
properties than SWCNTs. Their larger size and ease of manufacture led 
to use in many industrial sectors, including chemicals, electronics, 
clothing, as well as food, health care and biotechnology. Both SWCNTs 
and MWCNTs possess high tensile strengths, are ultra-light weight and 
have excellent thermal and chemical stability.  
The high aspect ratio (ratio between length and diameter), small 
diameter, long length, and durability in vivo of CNTs recall another 
particle with similar features: crocidolite asbestos fibers. Crocidolite 
asbestos fibers are the principle cause of mesothelioma and are also 
associated with lung inflammation and other cancers. Similar to asbestos 
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fibers and other nanoparticles, CNTs have been associated with the 




Figure 1. Basic SWCNTs (left) and MWCNTs (right) and typical transmission electron 
micrographs. (Adapted from Donaldson et al., 2006). 
 
 
Current Applications of Carbon Nanotubes 
 
CNT applications range from nanocomposites to imaging and treatment 
of diseases. CNTs are among the strongest and stiffest structures known, 
and have the strongest tensile strength of any synthetic fiber. As a 
consequence, the addition of MWCNTs to plastics and composites 
improves their conductive, mechanical, and flame barrier properties, 
allowing the construction of spacecraft structures, artificial muscles, 
combat jackets and land and sea vehicles [9,10].  
On the contrary, SWCNTs are less widely employed in industry, 
however, they are of great interest for their potential medical applications 
[11]. One of the most interesting applications of SWCNTs is as carrier 
for drug delivery and treatment, as CNTs are able to enter cells by 
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themselves. These CNTs are rarely employed as unmodified or pristine 
from, but rather “functionalized”. Pristine CNTs are inherently 
hydrophobic and aggregation is expected and observed in vitro and  in 
vivo. As a result, to make CNT soluble in water and biocompatible, the 
surface chemistry of raw material may be modified covalently or not 
covalently and this procedure is broadly defined functionalization This 
“functionalization” consists in the addition of functional groups on the 
surface of CNTs: the functional group added can be subjected to ordinary 
synthesis methods to attach virtually any kind of organic compound on 
the surface.  
Functionalization is able to change size and surface charge and alter the 
solubility and biocompatibility of CNTs. Among the different possible 
reactions developed to functionalize CNTs, oxidation and 
functionalization with polyethylene glycol (PEGylation) are the most 
popular. Although oxidation makes CNTs soluble in water, they 
aggregate in presence of salts, and so in most of the biological solutions 
and even if PEGylation makes CNTs and oxidized CNTs stable in 
solution, chemical reactions could destroy the physical characteristics of 
CNTs. 
CNTs could also be non covalently functionalized with amphiphilic 
compounds, used to lower the interfacial tension between the solvent and 
the particulate CNT. These functionalizations are promising for different 
biomedical applications including imaging: CNTs could also be 
functionalized by conjugation with fluorescence or radiolabelled probes, 
peptides and different molecules that allow the attachment of other 
molecules. Proteins can be also conjugated or absorbed on CNTs for 
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intracellular delivery. The addition of agents can also protect the particles 
from being sequestered by the Reticular Endothelial System (RES) 
largely composed of the liver and spleen, for which the most common 
functionalizing agent is PEG. Although “properly functionalized” 
SWCNTs are considered “free of toxicity”, there is a phenomenon of 
“defunctionalization”[12] which suggests that in vivo, particularly in the 
liver, CNTs can be reverted to a poorly functionalized state. Given the 
very long life of nanotubes in vivo, this may have implications in the 
hepatotoxicity and carcinogenic potential of functionalized nanotubes 
employed in medicine. 
 
Environmental and Occupational Exposures to Carbon 
Nanotubes 
 
To date, 190 facilities in Italy are working with nanotechnologies, of 
which 55% are public and 45% private enterprises. In 2011 the number 
of private organizations using nanotechnology was four times that of 
2004. The Italian regions with the highest concentration of public 
companies active in nanotechnology, are Lombardy and Lazio, followed 
by Piedmont, Valle d’Aosta and Emilia Romagna 
(http://www.nanotec.it/). Engineered nanoparticles are completely novel 
structures that are not found in nature and how these particles interact 
with biological organisms is to be completely discovered. This is the case 
of CNTs, whose unusual structure is completely new in terms of 
evolution and biology.  Many of the industries using MWCNTs are in the 
Lombardy area of Italy, and our data have been obtained using 
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commercially available MWCNTs used in a local industry. Currently 
there are no particular precautions employed for those working with 
CNTs in the industry setting.  For these reasons it is critical to investigate 
the question of their safety for human health.  
Fast propagation of nanotechnologies into different industries and 
consumer products is causing the exponential growth of nanomaterials 
production and as a consequence, of nanomaterial exposure. People could 
be exposed to CNTs by coming in contact with the aerosol form of CNTs 
during production or exposure as a result of environmental diffusion or 
biomedical use. Toxicity of CNTs is related to properties of the CNT 
material such as their structure, length and aspects ratio, degree of 
aggregation as well as to their concentration and dose. These physical 
characteristics determine the ability of CNTs to enter the environment. In 
the occupational setting, risk of exposure to nanomaterials could occur 
for workers at all phases of the material life cycle and depends on how 
product is being handled and at which phase: exposure could potentially 
occur during synthesis of the material or in transformation activities by 
exposure to airborne CNT dust. As previously reported [13], it is 
important to note that in some factories dust exposure due to lack of 
respect of industrial hygiene standards is found. 
The main exposure routes to CNTs are considered to be inhalation and 
dermal contact. Ingestion can also occur as a consequence of swallowing 
inhaled material following mucociliary clearance or as a result of hand-
to-mouth contact for individuals with exposure on their hands.  
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Figure 2. Possible pathways of occupational, environmental and human exposure to 
nanomaterials (modified from Hristozov D and Malsch I, 2009). 
 
 
Limited data and guidelines are available for handling CNTs in 
occupational settings as well as research laboratories. In this contest, the 
study by Pauluhn and collaborators [14] is of great value for setting 
guidelines for occupational exposure in workplace environment and 
deriving occupational exposure limits (OEL). However, there are 
currently no exposure limits specific to engineered nanomaterials and this 
requires a careful assessment of potential unexpected biological 
interactions and toxicities associated to CNTs. Due to the wide use of 
nanomaterials and CNTs in many industrial fields, nanotoxicology 
studies have shown that large concentrations of CNTs may be present in 
occupational environments [13], which deserve particular attention from 
the standpoint of exposure. 
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Toxicity of nanoparticles 
 
With the growing spread of nanotechnology, the necessity to understand 
the possible interaction of these new materials with the organisms gave 
birth of a new discipline, called Nanotoxicology. Initially, it was only 
considered a sub-category of toxicology defined ‘to address gaps in 
knowledge and to specifically address the special problems likely to be 
caused by nanoparticles’ [15]. It was supposed that nanoparticles and 
nanotubes may be able to induce adverse effects at their site of entry, for 
example, the lungs, but that some nanomaterials could also translocate 
from their site of entry to other target organs. At the time it was already 
known that nanoparticles in food can be adsorbed into the gut and 
redistribute to other organs more quickly than larger particles [16]. 
Currently, nanotoxicology has to be considered as ‘the other face of the 
coin’ of nanotechnology [17]. The same unique physical and chemical 
properties that make nanomaterials so promising for many uses may be 
associated with their potentially adverse or dangerous effects on 
organisms, cells and tissues. The toxicity of nanomaterials in the context 
of environmental and occupational diseases is not yet well understood: 
there is emerging concern that nanosized particles merit a particular 
assessment of their potential effects on health and environment as the 
toxicity of nanoparticles could be significantly greater than those of 
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larger particles. However, specific mechanisms and pathways through 
which nanomaterials may exert their toxic effects remain largely 
unknown. Although most people are still unfamiliar with 
nanotechnology, when CNTs move away from the production settings 
and the products became commercially available, the debate about the 
possible toxicities of these unnatural materials and their effects on 
workers and consumers is growing, that is why it is crucial to investigate 




Methodology to Assess the Potential Toxicity of Carbon 
Nanotubes  
 
Due to their structures and compositions, CNTs tend to bundle into 
aggregates [18]. From these structures, they can even form clumps larger 
than respirable size.  
Elucidating the in vivo effects of administered CNT is considered very 
important in the context of the safety of novel nanomaterials. CNTs are 
biopersistent and can accumulate in organs, in particular in the lungs and 
toxicity has been reported in rodent models by pharyngeal aspiration 
[19,20].intratracheal instillation [13,21,22], inhalation [19] and  
intravenous [1,23], subcutaneous [24] or intraperitoneal injection [25]. 
The size and biopersistence of nanotubes has been liken to that of 
asbestos, and there are extensive concerns regarding the potential health 
hazards of CNTs, mostly focusing on the lungs [26]. 
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Fibre toxicology and the experience with asbestos 
 
The unique nanometer-scale diameter, the needle-shape and the high 
aspect ratio make CNTs one of the most attractive structural material, but 
this fibrous structure has led to concern that they might cause asbestos-
like pathologies. 
The experience with asbestos and the resemblance between 
nanomaterials and asbestos has led scientists to assess the potential 
toxicity and the risks to public health associated to nanoparticles [27]. 
Several studies have evaluated the responses to CNTs in cell cultures and 
the lungs of animal models [13,28,29], but the hypothesis that CNTs can 
behave like asbestos at the mesothelium level has only been partially 
addressed [30]. The mesothelium is the lining that covers the internal 
faces of the pleural and peritoneal cavities (parietal mesothelium) and the 
exterior surfaces of the organs (visceral mesothelium). When cancer 
occurs in the mesothelium, as is the case of people exposed to asbestos, 
the cancer is termed mesothelioma [31]. Mesothelioma is almost 
exclusively found following asbestos exposure and is a unique response 
to fibre-shaped particles [32]. 
Fibre toxicology identifies the characteristics of fibres and their most 
important toxicological features involved in the biopersistence of fibres. 
Diameter is important, as small diameter allows deposition beyond the 
ciliated airways. The length is also a key factor in the pathogenicity of 
fibres: it has been demonstrated that carcinogenesis was linked to fibres 
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longer than 10 um and long CNTs showed similar ability to asbestos to 





Figure 3.  The frustrated phagocytosis paradigm relates to long and short fibres of 
asbestos (left) and various forms of carbon nanotubes (right). Macrophage can enclose 
short or tangled CNTs and clear them. However the macrophages are not able to enclose 
long asbestos or long nanotubes, resulting in incomplete or frustrated phagocytosis, 
which leads to inflammation (modified from Donaldson et al., 2010). 
 
 
Biopersistence and length influence the clearance of fibres, but not in the 
case of long fibres because they cannot be easily phagocyted by 
macrophages [34]. The failure of macrophage phagocytosis, called 
incomplete or frustrated phagocytosis, is a pro-inflammatory condition 
common to asbestos fibres and CNT longer than 15 μm [33]: it is 
possible for carbon nanotubes to be pathogenic by being thin, long and 
biopersistent and they can form tangles or ropes still thin enough to be 
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respirable. Graphene, the basic structural component of CNT is an 
exceedingly strong material and so is likely to be biopersistent [30]. 
 
Pulmonary toxicity of CNTs 
 
The difficult generation of fine dust containing CNTs or aggregates of 
respirable sizes for inhalation studies [35] and the difficult maintenance 
of exposure levels of CNT led researchers to assess the effects of CNTs 
in the lungs by intratracheal instillation (ITI). ITI consists in an 
administration of a bolus dose of an aqueous suspension containing 
CNTs directly instilled into the trachea of anaesthetized animals. 
Instillation studies reported significant pulmonary effects, including 
inflammation, evidence of oxidative stress, fibrosis [29], granuloma 
formation [13,28,29,36] and animal death [28]. The mechanism of 
lethality is associated with the formation of lung granulomas, in a dose- 
independent manner, and is probably associated with the impact of CNT 
aggregates that agglomerated the airways of animal models, inducing 
mortality in 15% of instilled rats within 24 hours post-instillation [28].  
However, it is presumed that CNTs with good biodistribution are not 
toxic enough to cause inflammation and formation of pathological 
structures in the lung because of the dispersibility. Lam and collaborators 
[13] showed that a single instillation of SWCNTs in mice induced 
persistent granulomas and inflammation. Moreover, the severity of lung 
lesions was dose dependent. Granuloma formation around CNT 
aggregates was observed in rats and mice [13,29]. In order to clarify if 
granuloma formation was induced by CNT impurities, Shvedova and 
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collaborators [29] employed purified SWCNTs administered by ITI, 
avoiding the generation of oxidant and they found acute inflammatory 
reaction characterized by a rapid increase in bronchoalveolar lavage 
(BAL) fluid levels of inflammatory cells [29], inflammatory cytokines, as 
TNF-α, IL- 6, TGF-β and increased collagen deposition [37]. However, 
the most important finding was the dose-dependent and progressive 
development of interstitial fibrosis in lung regions distant from CNT 
deposition sites. Inflammation and fibrosis were found to be present in 
lungs after 60 days [36]: after 2 months collagen-rich granulomas were 
observed in the lung of treated rats. Increased numbers of 
polymorphonuclear cells and protein exudates (fluid rich in protein and 
cellular elements that leach out of blood vessels due to inflammation), 
and high levels of LDH activity in BAL fluid were also observed [36].  
In other studies aerosolized MWCNTs did not induce obvious pulmonary 
toxicity in a 30-day exposure group but induced severe pulmonary 
toxicity in the 60-day exposure group [38]. The comparison between ITI 
administration and inhalation of MWCNTs revealed that the main 
pathological lesions were induced by aggregations, causing proliferation 
and thickening of alveolar walls. However, the general alveolar structure 
was still remained [38].  
Inhalation of MWCNTs more closely mimics occupational and 
environmental exposure because CNTs form more dispersed structures 
when compared to an instilled bolus dose administered in aqueous 
suspensions. Moreover, inhaled CNTs reach the distal regions of the lung 
and more accurately represent deposition and pathologic responses to real 
exposure scenarios. It has been shown that inhaled CNTs caused an 
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initial inflammatory response followed by granulomas, fibrosis and 
decreased rates of respiration, as well as activation of a gene that induces 
lung cancer [19]. 
 
 
Hepatotoxicity of CNTs 
 
Organisms have developed elaborate systems to defend themselves 
against toxic agents. Most cells in the body are capable to aid in the 
metabolism of toxic agents of metabolism, however the primary organ 
for detoxification is the liver and thus is the target organ to investigate 
the in vivo biocompatibility of CNTs.  
The oxidative stress and hepatotoxicity biomarkers are usually 
investigated by evaluation of ROS induction, measurement of LHP, 
activities of certain liver enzymes such as alanine transaminase (ALT), 
aspartate transaminase (AST), ALP and histopathological 
characterization of liver in mice exposed to MWCNTs [24,25]. Serum 
ALT and AST are important biochemical enzymes indicative of hepatic 
injury. 
AST is a pyridoxal phosphate (PLP)-dependent transaminase enzyme, 
which catalyzes the interconversion of aspartate and α-ketoglutarate to 
oxaloacetate and glutamate. In a subsequent step, oxaloacetate reacts 
with NADH and the conversion of NADH to NAD+ is proportional to 
the concentration of AST in serum. ALT catalyzes the transfer of an 
amino group from alanine to α-ketoglutarate, producing pyruvate and 
glutamate. Increasing of both ALT and AST reflects damage to the liver. 
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Several studies reported increased levels of both the enzymes after 
intravenous injection of pristine or functionalized CNTs [39]. In 
particular, Jain and collaborators [40] observed that MWCNTs induced 
severe hepatocyte mitochondrial damage as levels of AST, resident in 
cytosol as well as in mitochondria, were higher than ALT levels, which is 
present only in the cytosol. 
ROS has been implicated in the toxicity of carbon nanotubes by several 
authors [19,40,41,42]. Their formation with subsequent cellular damage 
is considered as the molecular mechanism of carbon nanotube-induced 
toxicity. Recently, it has clarified that acid oxidation or carboxyl 
functionalization is crucial to decrease the severity of oxidative stress 
induced by MWCNTs. In particular, it has been shown that the presence 
of metals is crucial for the generation of ROS, in fact acid-treated 
MWCNTs to remove metal contaminant or intensive purification are able 
to improve CNTs biocompability [40] 
Recently, it has been indicated that CNTs were trapped by the 
reticuloendothelial system and retained mainly in the liver of mice for 
long time periods after intravenous injection [43,44,45]. Hepatotoxicity 
involving an inflammatory response, mitochondria destruction and 
oxidative damage were observed following injection of functionalized 
MWCNTs, which also can affect several gene pathway expressions in 
mice, including GPCRs (G protein-coupled receptors), cholesterol 
biosynthesis, metabolism by cytochrome P450, natural-killer cell- 






The project that I carried out during my Ph.D course had the purpose to 
evaluate the biodistribution and the mechanisms of entry of MWCNTs in 
a simple mouse model that mimics the exposure to CNTs in the 
environment, since a main route of exposure to CNTs will be through 
environmental exposure (essentially through aerosol inhalation and the 
digestive tract contact, as exposure of the digestive tract occurs both by 
direct trapping in the saliva and by the physiological process of upper 
airway trapping and respiratory tract mucus removal).   
Data from body distribution in rodent model studies to date have been 
from intravenously administered CNTs [47] and are mainly focused on 
the systemic distribution of SWCNTs, as this kind of nanomaterials 
represent the elective choice for drug delivery or therapy. However, also 
in this context, toxicological data are conflicting.  
Toxicity induced by chronic exposure to MWCNTs, instead, is focused 
on the pulmonary effects. For these reasons, we are interested in 
clarifying how these particles enter and interact with biological systems 
and fill the gap regarding the paucity of data regarding possible adverse 
health outcomes resulting from chronic exposure to MWCNTs. 
We investigated the toxicity of an environmental MWCNT exposure, in 
particular evaluating the biodistribution, modes of entry and effects of 
CNTs in vivo  by: 
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1. Exploitation of a new, simple model of “workplace” exposure to 
investigate entry mechanisms; 
2. Evaluation of the role of CNTs in inducing hepatotoxicity, introduced 
in the animal model by intravenous injection. 
 
The aspect of novelty of this work is the exploitation of a new and simple 
in vivo model that mimics a probable workplace exposure scenario. Data 
from literature are mostly focused on lung toxicity since the main route 
of exposure is considered to be the respirable tract. Here we focused on 
the systemic distribution of MWCNTs and the associated toxicities 
The main goal of this study is the evaluation of the effects of CNTs 
exposure through a model that comprehends multiple routes of entry, in 
particular by the evaluation of hepatic injuries and the possible adverse 














MATERIALS AND METHODS 
 
CNT  preparation 
 
Commercially available, industrially employed, Multi-walled Carbon 
Nanotubes, NANOCYL
TM
  NC7000 (Belgium NANOCYL, Sambreville; 
average 9.5 nm diameter by 1.5 µm, not functionalized) used in this 
study were the kind gift of a local industry in Lombardy, the Italian 
region with the highest concentration of public companies active in 
nanotechnology. NC7000 were manufactured by CCVD, catalytic carbon 
vapor deposition process with a purity of 90%. 
SWCNTs were obtained from Sigma-Aldrich. The nanotubes cover an 
average diameter of 1.2-1.5 nm and 2 to 5 μm in length. For the 
preparation of suspended SWCNTs, the crude SWCNTs were dispersed 
in Dulbecco’s minimal essential medium (DMEM, Sigma Aldrich, 
Milan, Italy) supplemented with 10% (v/v) of serum of CD1 mice 
(CD1serum) using a sonication/centrifugation protocol based on that 
previously described by Yehia et al. [48] but with higher levels of 
endogenous serum to improve animal compatibility and avoid immune 
reactions to heterologous sera. Briefly, 10 mg of the crude SWCNT-
containing powder was dispersed in an microcentifuge tube containing 10 
ml of DMEM/CD1serum, vortexed for ~1 min, and probe sonicated for 
15 min at 0°C. Probe sonication was performed using a HD2070 
Bandelin Sonopuls sonicator (VWR International, Milan, Italy), a 2 mm 
diameter probe tip was placed one third of the distance below the surface 
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of the 1 ml suspension. The resulting suspension was centrifuged for 2 
min at 16,000 g and the upper 75% of the supernatant was recovered, 
placed in a clean tube and centrifuged for 2 min at 16,000 g. Again the 
upper 75% of the second supernatant was carefully recovered as the final 
SWCNT dispersion. 
 
Quantification of SWCNT concentrations 
 
To estimate the SWCNTs concentration in the samples used for the in 
vivo experiments we realized a calibration curve by means of FT-Raman 
measurements [49] on samples of known concentration. The band 
intensity was calculated as the average over several spectra of the G band 
peak integrated area from 1573 to 1612 cm
-1
 and the concentration of 
unknown samples determined using the calibration curve. 
 
Study design and animals 
 
The procedures involving the animals and their care were conformed to 
the institutional guidelines, in compliance with national and international 
laws and guidelines for the use of animals in biomedical research. The 
procedures used were approved by the local animal experimentation 
ethics committee and by the Health Ministry. Healthy adult male and 
female CD1 mice (6-8 weeks of age) were used in this study. The 
animals were housed with steel wire tops and corn-cob beddings, 
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maintained in a controlled atmosphere with 12-12 dark-light cycle, at a 
temperature of 22 ± 25 ºC and 50-70% humidity with free access to food 
and fresh water.  
For the murine environmental exposure model, mice were exposed to 
MWCNTs added directly within the cage litter twice a week, 1.5gr/80 gr 
litter. Standard rodent diet and water were provided ad libitum. The 
animals extensively agitate the litter, generating an aerosol that contains 
MWCNTs which cause also the exposure of the respiratory tract as well 
as the digestive tract, as particulate matter in the lungs trapped by the 
mucus is expelled into the esophagus along with direct ingestion. During 
the experimental process, the health status of the animals were monitored 
by examining for skin alterations, reactivity to stimuli, body weight as 
well as food and liquid intake.  Mice were sacrificed after 1, 2, 3, 4 and 5 
weeks after initiating exposure to MWCNTs and the organs (lungs, brain, 
kidneys, liver and spleen) were removed and either fixed in OCT and 
immediately stored in liquid nitrogen, or fixed 4% glutaraldehyde and 
stored at 4°C for subsequent histological staining. The presence and the 
biopersistence of MWCNTs was assessed by chemical disruption of 
portions of explanted tissues and analysis by SEM (see below).  
For the intravenous injection study, mice were exposed to three doses 
(0.16 mg/kg; 1.6 mg/kg; 6.4 mg/kg) of SWCNTs injected in the tail vain, 
either for acute or chronic treatment, the later consisted of injections once 
every three weeks for nine weeks. One group was chosen as negative 
control and treated with 200 µl of Dulbecco’s minimal essential medium 
(DMEM) supplemented with 10% (v/v) of CD1 serum (the medium used 
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to disperse the SWCNTs). Mice were sacrificed either 24 hours, three 
weeks or four months after the last injection (for chronic exposure) or 24 
hours after the first injection (for acute exposure). At sacrifice the 
internal organs were collected and processed for standard histology and 
scanning electron microscopy (SEM), blood was collected to produce 




Samples fixed in OCT were used to obtain 5µm sections, stained by 
crystal violet and basic fuschsin and subsequently observed under a light 
microscope (Olympus, Tokyo, Japan). Samples fixed in 4% 
glutaraldehyde were washed in 0.1 M cacodylate buffer pH 7.4 and 
postfixed with 1% osmic acid in cacodylate buffer, pH 7.4. After serial 
ethanol dehydration, specimens were saturated with a uranyle acetate 
solution in 90% alcohol for 30 minutes. Samples were transferred in 
propylene oxide and Epon-Araldite resin solution 1:1 for 1 hour. Thin 
(750 nm) sections were obtained with a Reichert Ultracut (Leica, Wien, 
Austria). For standard histology, the liver, spleen, lungs and kidneys 
were removed, washed with PBS and 20 mM EDTA to remove excess 
blood and fixed immediately in 4% formalin. After dehydration in a 
progressive series of ethanol, samples were clarified in xylene and 
paraffin embedded. 7µm sections were obtained and stained with 
haematoxylin & eosin (H&E) for histological examination and observed 
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under a light microscope (Olympus, Tokyo, Japan). At least 10 slides of 




Mice were housed for 24 hours after each injection and every week 
between the first, the second and the third injection in metabolic cages to 
collect urine and fecal samples and to analyze the food and water 
consumption. To analyze the fecal water, feces samples were weighed, 
placed in a thermostatic oven for an hour, and weighed again. 
 
Serum biochemical analysis 
 
At sacrifice blood samples were immediately collected and transferred 
into tubes, and allowed to clot for 60 min. After clotting, the sample was 
centrifuged 60 min at 7,500 g. The samples were stored at -80ºC until 
ready for analysis. Plasma TNF-α levels were determined by enzyme-
linked immuno assay (ELISA, Becton Dickinson, BD - San Jose, 
California, USA). The absorbance was measured on a microplate reader 
at 450 nm in a Versamax Microplate reader (MolecularDevice; Genoa, 
Italy) and the TNF-α concentration in experimental samples was 
calculated from a standard curve. Aspartate amininotransferase, alanine 
aminotransferase, alkaline phosphatase, azotemia and creatinine were 
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performed using Kuadro BPC+BioSed clinical automatic chemistry 
analyzer (Italy, Genoa). 
 
 
Flow cytometry analysis  
 
To analyze the CD45
+
 cells and the lymphocyte subpopulations, the 
animals exposed to SWCNTs were sacrificed, organs removed and 




 with 0.53 mM EDTA. A single 
cell suspension was obtained by mechanical procedure followed by lysis 
of red blood cells by ammonium chloride solution (ACK, lysing buffer 
1X, Life Technologies Europe, Monza, Italy)  and finally filtration 
through 50 µm Nylon filters. Flow cytometric analysis was performed 
with a CyAn instrument (Dako, Milan, Italy) using Spectraline and Flow-
Check FluoroSpheres (Dako) for instrument setting and compensation 
with standard gating procedures. 
Viable cells were selected according to physical parameters (side scatter 
vs forward scatter), CD45
+ 





using anti CD45 and anti CD31 (marker for endothelial cells) 
monoclonal antibodies (MAbs). The following MAbs directed against 
mouse surface markers: anti F4/80 (APC, MB8 clone, BioLegend, 
Cambridge, UK), anti Gr-1 (FITC RB6-8C5 clone, ImmunoTools, 
Fiersoythe, Germany), anti NK1.1 (APC PK136 clone, BioLegend) and 
to CD19 (PE PeCa1 clone, ImmunoTools) were used to identify 
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Determination of the presence of nanotube and their 
localization by Scanning Electron Microscopy 
 
SWCNTs and MWCNTs were observed directly in 750 nm Epon 
sections of lungs, livers and brain obtained from 5 weeks 
environmentally exposed mice and injected mice, they were then washed 
repeatedly in distilled water, dehydrated in an ascending scale of ethanol, 
critical point dried with CO2 and sputter- coated with a thin layer of gold 
in and Emitech 550 sputter coater and observed in backscattered electron 
(BSE) mode with a scanning electron microscope (Philips XL30 SEM 
FEG). 
Portions of the same samples obtained after 5 weeks of CNT 
environmental exposure were excised and digested in 5N KOH (Sigma 
Aldrich) for  2h, then washed repeatedly in dH20 to remove potassium 
salt, resuspended in 100 µl of dH2O and dried on a cover glass for 
scanning electron analysis. To enhance CNT signals, cover glass were 
sputter- coated with a thin layer of gold and observed in backscattered 
electron (BSE) mode with a scanning electron microscope coupled with 







Macroscopic effects of MWCNTs in environmentally exposed 
mice 
 
All animals environmentally exposed to MWCNTs showed no overt 
clinical signs and, unlike what reported by several studies on CNT 
toxicity, all animals survived and appeared healthy at the time of 
sacrifice. Mice showed no body-weight loss or an altered food and liquid 
consumption, nor any alteration of reactivity to stimuli, showing a good 
general health status. MWCNTs did not produce macroscopic lesions 
(Fig.1), except for the digestive tract, which was dark in exposed mice, 
suggesting MWCNT accumulation.  
 
Accumulation of MWCNTs in environmentally exposure mice 
 
Although MWCNTs did not induce macroscopic alterations, 
histopathological effects derived from MWCNTs exposure model were 
observed on liver, kidneys, lungs and brain explanted from both exposed 
and control mice. The MWCNT exposed tissue sections showed frequent 
patches of dark material, likely to be MWCNT aggregates deposited 
within the lungs, brain, liver and kidneys that were not observed in 
tissues from control mice (Fig. 2). MWCNTs accumulated primarily as 
aggregates, in particular the formation of dark material deposits seems to 
be time-dependent. Temporary, the first organ affected were the lungs, in 
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line that expected as the major route of exposure is the respiratory tract, 
where deposits were observed from the very beginning of the exposure 
period (Fig. 2, I and II weeks of exposure). In the lungs, MWCNTs 
persisted up to the end of the experiments. Surprisingly, also at the same 
early time points the brains of exposed mice showed the same brown 
deposits, but more numerous and less aggregated than those observed in 
lungs, suggesting that MWCNTs can rapidly reach the brain. This rapid 
route of entry may be directly through the nasal mucosa. Time-dependent 
systemic distribution of MWCNTs involved the liver and kidneys, which 
presented the same brown aggregates observed in the lungs, but only 
after 4 weeks of MWCNTs administration (Fig. 2). Taken together, these 
data suggest that MWCNTs in an environmental exposure model are able 
to quickly reach the distal organs, through the blood stream of exposed 
mice (see below), where they either directly deposit as aggregates or re-
aggregate in liver, lungs, brain and kidneys.   
 
Dark deposits of material in exposed mice are MWCNTs 
aggregates 
 
The brown deposits were observed only in lungs, liver and brain of 
MWCNT exposed mice, suggesting that these are due to the presence of 
MWCNTs in these organs. The presence of MWCNTs in these tissues 
were confirmed by taking advantage of the chemical resistance of CNTs. 
Tissues from exposed and control groups were mechanically dispersed 
and digested with KOH to remove tissue derived material, the resistant 
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material was collected by centrifugation. This procedure resulted in a 
visible black material that SEM analysis revealed had the characteristics 
of aggregates of CNTs that were very similar to the starting material, 
before and after KOH exposure (Fig. 3D, 3E and 3F).  This procedure 
revealed CNTs from the liver, brain and lung (Fig. 3A, 3B and 3C). 
Similar structures were found in blood samples taken form MWCNT 
exposed mice after 3 weeks (data not shown), indicating that CNTs enter 
into the blood stream. In combination with SEM analysis, Energy- 
dispersive X-Ray analysis spectrometry was performed on selected areas 
to detect and visualize the distributions of carbon. Elemental analysis 
clearly showed co-localization of carbon with the MWCNT aggregates 
(Fig. 4A and 4B). To confirm these data, we performed SEM analysis 
directly on a semithin section of 750nm , demonstrating the presence of 
MWCNT aggregates in liver (Fig. 4C).  
 
Hepatic steatosis in animals environmentally exposed to 
MWCNTs 
 
When we examined the liver tissues by scanning electron microscopy we 
observed an accumulation of lipid vesicles in the hepatocytes from 
animals exposed to MWCNTs (Fig. 4C and 4D).  These were not 
observed in untreated animals, indicating that environmental exposure 
leads to CNT transport in the blood stream to the liver, where it interferes 
with liver function and metabolism. While no overt signs of pathology 
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were observed in the exposed mice, steatosis is indicative of subclinical 
hepatic stress. 
Intravenously injected CNTs accumulate in liver and induce 
hepatic damage 
 
Environmental exposure to MWCNTs indicates that CNTs are able to 
enter into the blood stream and targeting diverse organs, in particular the 
liver, where steatosis is suggestive of hepatic damage. Since previous 
studies have suggested that injected MWCNTs or SWCNTs showed 
similar hepatotoxicity profiles in mice [24,25], and SWCNTs have also 
been proposed for their therapeutic potential, we choose further 
investigate the systemic toxicity of CNTs, by acute or chronic 
intravenous injection of SWCNTs.  
Macroscopic analysis of organs harvested from mice chronically treated 
with the highest doses of SWCNTs (6.4 mg/kg dose) and sacrificed three 
weeks after the third injection indicated that the liver had a 
macroscopically darker color (Fig.5, panel A). These data suggest that 
the injected CNTs localized in these tissues. The kidney was affected to a 
lesser extent (Fig.5, panel A). Similar results were obtained in animals 
sacrificed 24h and four months after the third administration (data not 
shown). No differences in the weight of either mice or organs analyzed 
were observed (Table 1). As, observed in animals environmentally 
exposed to MWCNTs, histopathology analysis confirmed the 
accumulation of an amorphous brown material only in CNT treated mice 
representing SWCNT deposits.  These were particularly evident in the 
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liver and, unlike in the environmentally exposed mice, also in the spleens 
of all samples analyzed, 24 h (data not shown) and 3 weeks after the last 
injection. These deposits were found in the lungs at acute time points 
(animals sacrificed 24 h after the first injection, Fig.6, panel A) but these 
were cleared by the three-week time point (Fig.6, panel B) . Although the 
accumulation of what appears to be aggregated SWCNT deposits was 
observed in livers of treated animals, these organs otherwise showed 
normal structure with compactly arranged hepatocytes and sinusoids with 
uniform morphology. No significant alterations were observed in the 
kidneys. We also performed KOH disgregation on these tissues as above 
that revealed large aggregates of SWCNTs in the livers of injected mice 
(Fig. 5A), while these deposits were not found in tissues from control 
animals. SEM analysis of thin section of the liver showed aggregates, 
likely to be SWCNTs, in the sinusoids of the liver associated with 
Kupffer cells (Fig.5B, 5C and 5D).  
   
SWCNTs injection impairs metabolic functions  
 
We examined the effects of CNTs on food and water consumption as 
well as fecal and urine production using metabolic cages. Following the 
first administration of SWCNTs there was a trend toward augmented 
water and food consumption (Fig. 7A and 7B), accompanied by a 
statistically significant increase in feces production (Fig. 7C). Urine 
production was not affected (Fig. 7D). Similar effects were reported for 
all SWCNT doses, and most parameters returned to near baseline at three 
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weeks from the last administration, in particular for the highest dose. 
These data indicate that intravenous SWCNTs may interfere with the 
metabolism and digestive tract function.  
 
SWCNTs can induce chronic hepatic damage  
 
The alterations in food consumption and fecal production suggested 
potential adverse effects within the digestive tract.  We therefore 
examined several serum parameters reflecting renal and hepatic function. 
No differences were observed in creatinine levels between treated and 
control mice (Fig. 8A) while azotemia decreased in mice exposed to 
acute and chronic doses of SWCNTs (Fig. 8B). Taken together with the 
lack of effect on urine production, these data suggest that kidney function 
was not significantly affected by SWCNT administration.  
Examination of enzymes reflecting liver damage or malfunction showed 
a trend towards increased levels of alkaline phosphatase (Fig. 8C) at all 
doses, and significant increases in the levels of alanine aminotransferase 
(Fig. 8D) and aspartate aminotransferase (Fig. 8E), particularly for the 
highest dose.  While alanine aminotransferase levels, which increased 
significantly for the highest dose, returned to baseline after 3 weeks, 
aspartate aminotransferase remained elevated even after 3 weeks and for 
all doses.  Taken together, these data suggest that chronic exposure to 
SWCNTs can induce hepatic damage.  
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SWCNTs introduced into the blood stream are captured by 
RES system inducing inflammation and choleostasis 
 
To investigate if SWCNT treatment results in inflammation of key 
organs, we examined the influx of CD45
+ 
cells (a marker for all immune 
cells) into various organs. In the case of acute treatment, 24 h after the 
first injection of SWCNTs, we observed an increase of CD45
+
 cells in the 
lung at all doses (Table 2), as this is probably the first area affected 
following intravenous injection.  Increases in CD45
+
 cells were also 
observed in the liver after 24 hours at the highest dose (6.4 mg/kg).  The 
numbers of CD45
+
 cells were elevated in both liver and particularly in 
the spleen even three weeks after the last SWCNT administration (Table 
2). Interestingly, analyses of the lymphocyte subpopulations three 
months following the last SWCNT injection showed that the CD45
+
 cells 
remained elevated in the spleen, with increased levels of NK, 
macrophages, neutrophil granulocyte and B cells (Table 2). 
To evaluate the immune response further, we measured levels of TNFα, 
an indicator of inflammation, necrosis and fibrosis, in the serum. TNFα 
was elevated in the serum at the highest dose both at 3 weeks and at 3 
months after the last dose (Fig. 8F). These data suggest that SWCNTs 







Nanomaterials and nanoparticles have received considerable attention 
recently due to their unique properties and applications in diverse 
biotechnology and life science applications but also in many areas of 
industry. Despite the rapid progress and early acceptance of 
nanobiotechnology, the potential for adverse health effects due to 
prolonged exposure at various concentration levels, in humans and the 
environment has not yet been established. However, the environmental 
impact of nanomaterial is expected to increase substantially in the future. 
In particular, the behavior of nanotubes and nanoparticles inside the cells 
and cellular responses induced by these nanotubes or particles are still 
not well understood.  
In this study, we focus on the environmentally exposure model that, in 
our opinion, represents a more realistic scenario of exposure compared to 
the usual instillation or inhalation procedures explored by several works 
[13,19,29,41], in particular on the hepatotoxic effects due to chronic 
exposure and the eventual implications in neurodegenerative diseases. 
In vivo studies on CNT pulmonary toxicity are currently discussing about 
the best protocol to be used to administrate CNTs. It has to be considered 
that, while inhalation is the most physiological method, it is impossible to 
quantify the administrated quantity of CNTs, [50]. ITI is the most 
common administration method, but CNTs tend to create large 
agglomerate dispersed in suspension in saline that could lead to 
overestimation of the toxicity induced by CNTs.  
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Due to the implications that CNTs may adversely affect human health 
and safety, dosing of animals with an adequate amount of MWCNTs is 
fundamental for mimicry human exposure levels. The National Institute 
for Occupational Safety and Health (NIOSH) proposed 7 µg/m
3
 as lowest 
detectable level for CNTs respirable dust [51]. The dose used in this 
study, 1.5 g/80 g of litter (the average mouse used weighed 27 g, thus 55 
µg of MWCNT/mouse), were selected based on doses reported in 
previous exposure studies [33]. CNTs were directly dispersed in the 
litter, where the mice generate a local aerosol containing CNT dust. The 
dispersed MWCNTs also enter into the digestive tract of the animals: the 
combination of these two routes of entry, together with skin contact, 
seems to be a more realistic way in which humans could be in contact 
with CNTs. Data from this study demonstrated that if MWCNTs in the 
environmental or occupational settings will be present in a chronic 
manner, they can penetrate into the organism and rapidly spread in the 
whole body, without causing any overt clinical signs. We showed that in 
this model, MWCNTs can form aggregates, ropes and tangles, yet they 
are still thin enough to be in the respirable size range. The high aspect 
ratio, ratio of length and width, the nanometer-scale diameter and needle-
like shape have draw comparisons with asbestos, which, however, had 
the lungs as target, resulting in lung cancers, mesothelioma and 
asbestosis [52], while we find that MWCNTs seem able to reach the 
distal organs through the blood stream.  
It has to be considered that, unlike that previously reported for CNT 
inhalation or instillation studies [13,19,28,36], we did not found the 
formation of granulomas or fibrotic tissues: this suggests that the 
 38 
damages induced by CNTs in inhalation or instillation studies may be 
quite different from that where CNTs enter through environmental 
exposure. This represents another feature in common to asbestos, whose 
exposure causes clinical signs only after many years. 
MWCNT aggregates did not affect only the lungs following acute 
administration, but also the brains of exposed mice. We observed dark 
deposits of MWCNTs in brain soon after the first administration. These 
data suggest that either CNTs are able to form aggregates thin enough to 
penetrate deep into the alveolar region of the lung, then translocate into 
the blood circulation where they preferentially cross the blood brain 
barrier, or a more likely scenario of transport from the olfactory nerve 
into the olfactory bulb and dispersion to other areas of the brain. The 
ability of nanomaterials to move in the body and reach the central 
nervous system and heart, spleen, kidney, bone marrow, and liver was 
previously shown only after intravenous injection. Our data demonstrate 
that CNTs are able to form stable and  numerous deposits in brain even 
after acute exposition, without being rapidly cleared. Accumulation in 
fact seems to be dose and time dependent, we found greater MWCNTs 
after a chronic 5 weeks exposure.   
The capacity of CNTs to reach the distal organs may depend on their 
chemical reactivity, surface characteristics and ability to bind the body 
proteins. CNTs translocation in distal regions by intravenous 
administration is expectable, but with this study we are able to 
demonstrate that MWCNTs can distribute into the body in an 
environmental exposure model likely reflecting a real exposure scenario. 
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What we were interesting in was the ability of MWCNTs to accumulate 
in the liver, mechanism that induced hepatotoxicity, as demonstrated by 
the SWCNTs injection model, but did not cause obvious damage to the 
whole organ, neither lesions to the architecture. MWCNT accumulation 
in the liver due to a respiratory/gastrointestinal route of entry has not 
been previously reported. Livers appeared to be affected after 3 weeks of 
exposure and the accumulation of CNTs was continuous until the end of 
the experiment. Surprisingly, we observed a diffuse steatosis in 5 week 
treated mice, confirmed by both histological analysis and SEM 
observation, in spite of clinically healthy status. So, we hypothesize that 
the chronic exposure to MWCNTs led to development of hepatic injury. 
However, the absence of macroscopic alterations even in the presence of 
a diffuse hepatic injury, led us to investigate the specific role of CNTs in 
the development of hepatotoxicity following a chronic administration 
induced by intravenous injection, also determining tissue inflammation 
and differential body distribution. Intravenously administration of CNTs 
revealed that chronic administration of CNTs impairs metabolic 
functions, induces chronic hepatic damage and that CNTs are captured by 
RES system inducing inflammation and choleostasis. Examination of 
liver enzymes reflected liver damage or malfunction and showed 
increased levels of alkaline phosphatase and significant increases in the 
levels of alanine aminotransferase and aspartate aminotransferase.  
However, there is little effect on renal function, as confirmed by the lack 
of effect on urine production and the normal level of azotemia.  
Taken together, our data suggest that CNTs can rapidly enter and diffuse 
in the organism after environmental exposure. The data indicate that the 
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major organs affect may not be the lungs, which appear to have a 
capacity to clear the CNTs, but rather the liver and brain, where long 
term accumulation results in inflammation, leading to steatosis and 
hepatic damage in the liver. The effect of CNTs on the CNS, including 















































Figure 1: Organs collected after two and five weeks of treatment with MWCNTs. 
Macroscopic analysis indicated no evidence of lesions except for the digestive tracts 
which appeared darker, due to the direct ingestion of MWCNTs or ingestion of mucus 







Figure 2: Morphological changes of mouse organs exposed to environmentally 
administered MWCNTs. Arrows show dark deposits corresponding to MWCNT 
aggregates. Bars: 100 um. 
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Figure 3: SEM analysis following KOH digestion confirmed the presence of MWCNTs 
in the liver (A), brain (B) and lungs (C) of 5 weeks exposed animals. SEM 
characterization of aggregates of MWCNTs crude powder (D), before (E) and after (F) 








Figure 4.Combination of SEM analysis of MWCNT in liver (A) with elemental analysis 
(EDAX, B) clearly showed co-localization of carbon with the MWCNT aggregates. 
SEM analysis confirmed the accumulation of lipid vesicles in the hepatocytes from 








Figure 5. Organs collected 3 weeks after the final administration of SWCNTs. The liver 
shows macroscopically a darker color, as did the spleen, which was enlarged (Panel A). 
SEM analysis on liver 6.4 mg/Kg treated, revealed the presence of aggregated SWCNTs 
associated with portal spaces (B, indicated by *) and sinusoids (C, indicated by ▲).D: 
Magnification of  figure 3B. 
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Figure 6: Histopathological analysis of organs in SWCNT treated mice stained with 
H&E. We observed an accumulation of an amorphous brown material, indicated by 
arrows, likely representing SWCNT deposits in the liver and spleen in all samples 
analyzed, 24 h after the first injection (Panel A) and 3 weeks after the last injection 
(Panel B). Accumulation in lungs occured only after acute treatment with SWCNTs, but 






































































Figure 7. Consumption of food and water, and production of urine and feces as well in 
samples collected after 24h from the first injection ,24h from the last administration  
and three weeks after the last injection of SWCNTs. Data are expressed as mean( n > 6)  
± SD. Statistically significant *= p<0.05, **=0.001 using ANOVA followed by 
Dunnett's test.  
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Figure 8.Effect of SWCNTs on the level of creatinine, azotemia,aspartate 
aminotransferase (GOT), alanine aminotransferase (GPT) alkaline phosphatase and 
TNFα in the serum of SWCNT treated and control CD1 mice. Each experiment was 
done in triplicate.  Data are expressed as mean (n > 6)  ± SD. Statistically significant 






















Spleen (g)                                         Liver (g)
Ctrl 0.125±0.031       0.135± 0.017              1.543 ±0.261        1.631 ±0.122      
0.16 mg/kg   0.105±0.007       0.130 ±0.042              1.163 ±0.015        1.520 ±0.183
1.6 mg/kg     0.123±0.006       0.255 ±0.230              1.32 ±0.124          1.447± 0.105
6.4 mg/kg     0.110± 0.010      0.159 ±0.016              1.317 ±0.047        1.537± 0.098
24h after I       3weeks after III                24h after I     3weeks after III   
 
Table 1. Macroscopic alterations obseverd in harvested spleen and liver (see Figure 5) 
do not corrisponde to a significant alteration in organ weights, even for the highest dose 
administered 
 
Table 2. Flow cytometic analysis for CD45+ cells (a marker for all immune cells) in 
different organs harvested 24 h after the first injection, 3 weeks after the last injection or 
3 months after the last injection. Each experiment was done in triplicate.  Data are 
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